In this issue:
- Treatable traits in primary-care patients with obstructive lung diseases
- Telerehabilitation for chronic respiratory diseases
- COPD and its psychological effects: impact on community physical activity participation
- ICSs and major CV events in COPD
- ECG-based factors for adverse cardiopulmonary events in COPD
- Lung function decline in young smokers with normal spirometry
- Mepolizumab to prevent exacerbations of eosinophilic COPD
- Benralizumab for eosinophilic exacerbations of COPD/asthma
- Serum IgG levels are associated with COPD exacerbation risk
- Chest wall mobilisation in severe COPD
- Varenicline for nicotine vaping cessation in youth
- Dyspnoea in respiratory symptoms without defined diagnosis
Please login below to download this issue (PDF)